5-Fluorouracil (5-FU)

Nucleobase analog for in vitro and in vivo cytotoxicity assays

5-Fluorouracil is a fluorinated analog of uracil. 5-FU is approved by the U.S. Food and Drug Administration (FDA) for cancer chemotherapy as an antineoplastic, antimetabolic agent. Lately with the development of gene therapy, 5-FU can be used in combination with the uracil phosporibosyltransferase suicide gene.


CAS number: 51-21-8
Molecular weight: 130.1
Working concentration: 1 - 300 μg/ml

Uracil phosporibosyltransferase genes:
S.cerevisiae, E.coli

Cytosine Deaminase (CD) fused to uracil phosphoribosyl transferase genes:
S. cerevisiaeE.coli


- 250 mg at 10 mg/ml


Recent articles using InvivoGen 5-Fluorouracil (5-FU)



Description DNA synthesis inhibitor
Cat. Codesud-5fu
Unit Size250 mg
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".